Vimarsana
Biggest News Aggregation in the World

Certain Line Items News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Certain Line Items. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Certain Line Items Today - Breaking & Trending Today

Jazz Pharmaceuticals Announces First Quarter 2024 Financial Results and Affirms 2024 Financial Guidance - Vimarsana News

Jazz Pharmaceuticals Announces First Quarter 2024 Financial Results and Affirms 2024 Financial Guidance

– 12% year-over-year revenue increase from combined key growth drivers: Xywav®, Epidiolex® and Rylaze® –– Oncology revenues grew 13% year-over-year –– Submitted zanidatamab BLA for 2L...

Dada Announces Unaudited Fourth Quarter and Fiscal Year 2023 Financial Results - Vimarsana News

Dada Announces Unaudited Fourth Quarter and Fiscal Year 2023 Financial Results

SHANGHAI, China, March 25, 2024 (GLOBE NEWSWIRE) -- Dada Nexus Limited (NASDAQ: DADA, “Dada” or the “Company”), China’s leading local on-demand retail and delivery platform, today announced its unaudited financial

Jazz Pharmaceuticals Announces Third Quarter 2023 Financial Results and Updates Financial Guidance - Vimarsana News

Jazz Pharmaceuticals Announces Third Quarter 2023 Financial Results and Updates Financial Guidance

/PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced financial results for the third quarter of 2023 and provided business updates....

Jazz Pharmaceuticals Announces Third Quarter 2023 Financial Results and Updates Financial Guidance - Vimarsana News

Jazz Pharmaceuticals Announces Third Quarter 2023 Financial Results and Updates Financial Guidance

/PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced financial results for the third quarter of 2023 and provided business updates....

Jazz Pharmaceuticals Announces Second Quarter 2023 Financial Results and Raises 2023 Full Year Financial Guidance - Vimarsana News

Jazz Pharmaceuticals Announces Second Quarter 2023 Financial Results and Raises 2023 Full Year Financial Guidance

– Strong execution delivered second quarter 2023 total revenues of $957 million – – Commercial excellence drove continued adoption of low-sodium Xywav®; net...